Paragon 28, Inc. (NYSE:FNA – Get Free Report) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 5,300,000 shares, a growth of 14.0% from the May 31st total of 4,650,000 shares. Currently, 14.3% of the company’s shares are sold short. Based on an average trading volume of 720,500 shares, the short-interest ratio is presently 7.4 days.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. acquired a new stake in Paragon 28 during the fourth quarter worth approximately $25,000. HighMark Wealth Management LLC acquired a new stake in shares of Paragon 28 during the 4th quarter worth $99,000. Price T Rowe Associates Inc. MD increased its position in shares of Paragon 28 by 16.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock worth $156,000 after purchasing an additional 1,766 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Paragon 28 by 26.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,886 shares of the company’s stock valued at $173,000 after purchasing an additional 2,902 shares in the last quarter. Finally, Capstone Investment Advisors LLC bought a new stake in Paragon 28 during the fourth quarter worth about $249,000. Institutional investors own 63.57% of the company’s stock.
Paragon 28 Stock Performance
Shares of FNA traded down $0.06 during mid-day trading on Wednesday, reaching $6.56. The company’s stock had a trading volume of 60,370 shares, compared to its average volume of 614,663. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.78 and a current ratio of 3.57. Paragon 28 has a 1-year low of $5.55 and a 1-year high of $18.50. The business has a 50-day simple moving average of $7.65 and a two-hundred day simple moving average of $10.27.
Analyst Upgrades and Downgrades
Several research firms have weighed in on FNA. Needham & Company LLC cut their target price on shares of Paragon 28 from $17.00 to $14.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. JMP Securities dropped their price objective on Paragon 28 from $23.00 to $20.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 9th. Stephens reissued an “overweight” rating and issued a $18.00 target price on shares of Paragon 28 in a research note on Friday, April 5th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $15.00 price target (down previously from $18.00) on shares of Paragon 28 in a research report on Thursday, May 9th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Paragon 28 presently has a consensus rating of “Buy” and a consensus target price of $16.75.
Read Our Latest Stock Analysis on FNA
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Further Reading
- Five stocks we like better than Paragon 28
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- GitLab Stock Rebounds: The Inside Story of Its Comeback
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Is Rivian Stock on the Verge of a 100% Rally?
- Investing in Travel Stocks Benefits
- Clarivate: The Cheapest AI Stock Worth Buying?
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.